Access Statistics for Patricia M. Danzon

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality 0 0 0 391 1 1 16 1,215
Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets 0 1 2 77 3 6 23 287
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets 0 0 1 248 2 5 24 833
Mandated Employment-Based Health Insurance: Incidence and Efficiency Effects 0 0 0 2 2 2 8 489
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries 0 0 0 1,504 2 3 22 4,646
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement 1 1 1 102 3 5 18 230
Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? 0 0 0 7 0 0 13 33
Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy 0 0 0 1 1 1 7 9
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances 0 0 0 543 2 2 23 2,007
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand 0 0 0 355 1 2 16 1,175
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 0 1 1 7 682
The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s 1 1 1 295 3 3 18 793
Vaccine Supply: Effects Of Regulation And Competition 0 0 0 23 1 4 15 183
Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 1 57 0 0 18 190
Total Working Papers 2 3 6 3,605 22 35 228 12,772
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
"Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market 0 0 0 41 1 2 6 201
A general model of the impact of absenteeism on employers and employees 0 0 1 145 2 2 8 737
A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth 0 0 0 18 1 2 8 71
Alternative Liability Regimes for Medical Injuries 0 0 0 2 0 1 10 27
At what price? 0 0 0 0 0 0 7 8
Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions." 0 0 0 0 1 1 3 300
Contingent Fees for Personal Injury Litigation 0 0 0 83 3 3 8 878
Cross-national price differences for pharmaceuticals: how large, and why? 0 0 1 323 2 3 21 768
Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues 0 0 1 16 0 0 14 68
Does Regulation Drive out Competition in Pharmaceutical Markets? 1 1 3 38 2 2 16 1,202
Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion 0 0 0 81 0 0 8 231
Health Care Reform 0 0 0 4 0 1 9 37
Health Insurance and the Growth in Pharmaceutical Expenditures 0 0 0 13 1 1 19 80
Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment 0 0 0 4 2 3 10 258
Hospital `profits': The effects of reimbursement policies 0 0 0 38 2 3 8 149
Liability and liability insurance for medical malpractice 1 1 1 61 3 3 9 197
Liability for Medical Malpractice 0 0 0 199 1 1 12 696
Medical negligence and the NHS: an economic analysis 0 0 0 1 2 3 10 172
Mergers and acquisitions in the pharmaceutical and biotech industries 1 1 2 341 5 8 34 1,144
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement 0 0 1 8 2 6 13 68
Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? 0 0 0 10 4 4 7 45
Price Cutting in Liability Insurance Markets 1 2 4 115 2 5 20 498
Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU 0 2 2 159 1 6 23 450
Price, Financial Quality, and Capital Flows in Insurance Markets 0 0 0 122 2 5 14 415
Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances 0 0 1 126 4 5 29 632
Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance 0 0 0 78 1 1 9 664
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 0 77 1 3 9 469
Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 1 3 5 94 4 7 31 345
Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 0 0 0 7 7 7 14 36
Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 0 0 0 6 2 2 7 61
Separation of the redistributive and allocative functions of government: A public choice perspective 0 0 0 70 2 2 8 476
The Economic Implications of Public Disability Insurance in the United States 0 0 0 46 0 2 5 212
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 54 2 3 14 201
The Frequency and Severity of Medical Malpractice Claims 0 0 0 8 0 0 6 604
The Political Economy of Workers' Compensation: Lessons for Product Liability 0 0 0 10 1 3 10 75
The Swedish patient compensation system: Myths and realities 0 0 0 95 0 0 4 233
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s 2 2 2 91 4 6 33 401
Tort Liability: A Minefield for Managed Care? 0 0 0 0 4 4 9 241
Tort Reform: The Case of Medical Malpractice 0 0 0 0 3 3 6 467
Vaccine Supply: Effects of Regulation and Competition 0 0 0 26 2 2 8 202
Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 3 25 2 2 17 165
Welfare effects of supplementary insurance: a comment 0 0 0 25 2 2 9 85
Worker's Compensation Rate Regulation: How Price Controls Increase Costs 0 0 0 2 3 3 11 444
Total Journal Articles 7 12 27 2,662 83 122 536 14,713


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison 0 0 1 8 0 8 31 103
The Life Cycle of Pharmaceuticals: A Cross-National Perspective 0 0 2 5 0 9 16 54
Trade and Price Differentials for Pharmaceuticals: Policy Options 0 0 0 23 2 7 21 123
Total Books 0 0 3 36 2 24 68 280


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets 0 0 0 1 1 2 10 15
Liability for medical malpractice 0 0 0 673 6 8 26 3,367
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 0 44 2 2 12 215
Regulation of the Biopharmaceutical Industry 0 0 1 17 2 3 8 35
Regulation of the Pharmaceutical-Biotechnology Industry 0 0 0 162 3 5 30 506
The Effects of Price Regulation on Productivity in Pharmaceuticals 0 0 0 22 1 1 10 83
Total Chapters 0 0 1 919 15 21 96 4,221


Statistics updated 2026-11-12